Johns Hopkins Kimmel Cancer Center, Sibley Memorial and Suburban Hospitals

The Ride to Conquer Cancer: Your Dollars at Work


Since 2014, The Ride has raised over $2.6 million for Johns Hopkins Medicine.

Funds raised through The Ride to Conquer Cancer support vital cancer research and accelerates transformational cancer discoveries at Johns Hopkins Kimmel Cancer Center, Sibley Memorial, Suburban and Howard County General Hospitals.

The Johns Hopkins Kimmel Cancer Center is one of 41 comprehensive cancer centers designated by the National Cancer Institute. Their world-leading doctors, researchers, scientists and clinicians are dedicated to providing patients with the best possible treatment and quality of care. Through expert, multi-disciplinary teams, the Kimmel Cancer Center is able to provide patients with individualized treatment plans. Because their Doctors, Research Scientists and Clinicians work closely together, patients have access to some of the most innovative and advanced therapies in the world. New drugs and treatments developed in the laboratory are quickly being transferred to the clinical setting, offers patients constantly improved therapeutic options.

Sibley Memorial Hospital in Northwest Washington, D.C., was founded in 1890 and the hospital’s Sibley Cancer Center is dedicated to comprehensive and coordinated care with state-of-the-art technology and recognized medical experts on staff. From surgery to radiation oncology to psychosocial support, the Sibley Cancer Center offers patients and their families a calm and private setting and the high level of patient care that is Sibley's hallmark. The Cancer program at Sibley includes the Sullivan Center for Breast Health and the Sibley Center for Gynecologic Oncology & Advanced Pelvic Surgery.

Suburban Hospital in Montgomery County, Maryland was established in 1943 and serves the surrounding areas. Suburban Hospital is affiliated with many local health-care organizations, including the National Institutes of Health.

Howard County General Hospital in Howard County, Maryland has been serving the greater Howard County community for more than 40 years as a non-profit hospital with a mission to provide high-quality, comprehensive care and improve the health of its community. In 1998, the hospital entered into a strategic partnership with Johns Hopkins Medicine, thereby further strengthening the community-focused, integrated delivery system already in place. The alliance with Hopkins has positioned Howard County General Hospital to pursue new initiatives that provide improved services, facilities, and medical technology to the residents of Howard County.

Today, Howard County General Hospital provides residents of the greater Howard County community access to an array of comprehensive cancer services. Integrated care across surgical, radiation, and medical oncology offers patients and families comprehensive treatment options and access to cutting edge clinical trials. The Breast Center is the only specialized clinic of its type in Howard County, offering technologically-advanced screening, diagnostic, and treatment options coordinated by expert surgeons, oncologists, and radiation oncologists. Patients and families also have access to the Claudia Mayer / Tina Broccolino Cancer Resource Center, which offers individually tailored services to assist those affected by cancer by connecting them to resources, teaching coping skills, and providing emotional support.

Johns Hopkins Medicine uses Ride funded dollars to enable the continuity of vital cancer programs including across these institutions and specific programs include:

Haploidentical Bone Transplants - Physician-scientists at Johns Hopkins have developed a half-matched bone marrow transplant procedure that has been successful in “curing” patients of some cancers and blood disorders, such as sickle cell anemia. Fund raised by Riders is being used to power these procedures at Johns Hopkins Medicine. Rather than wiping a patient’s immune system before transplanting donor bone marrow, doctors administer enough chemotherapy to suppress the immune system, which keeps patients from rejecting the donated marrow without harming their organs. As a result, the side effects are much milder and only half of patients may need to be admitted to the hospital. This procedure also greatly expands the potential donor pool, making more patients eligible for the transplant.

Immunotherapy - To make cancer cells more vulnerable to attack by the immune system, Johns Hopkins researchers are harnessing the immune system with the PD-1 checkpoint inhibitor to treat lung cancer, kidney cancer and melanoma. Physician-scientists at Johns Hopkins have developed an innovative treatment vaccine that seeks out and destroys pancreas cancer cells, one of the most deadly cancers and many times resistant to standard therapy. Funds raised through The Ride enable the continuity of these treatment programs.

Next Generation Gene Sequencing and New Screening Tests - Ride dollars are powering next generation programs which use cervical fluid obtained to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected them all. This new type of gene sequencing has the potential to lead to more tests that find cancers early and also determine whether treatments are working.